Ventria Logo Ventria Bioscience
   

Ventria Announces Randy Semadeni, Vice President of Finance and Business Development

March 7, 2007 – Ventria Bioscience announced today that Randy Semadeni would be joining the company as Vice President of Finance and Business Development.

Semadeni joins Ventria’s management with more than 15 years of experience in Finance and Business Development. Prior to joining Ventria, Randy led the commercial launch of two business units for Rembrandt Enterprises. Randy has also held finance leadership positions with Murphy Farms, a division of Smithfield Foods, and Koch Industries.


" Randy’s demonstrated success in finance and business development will provide the expertise needed for Ventria to commercialize its product pipeline,” said Scott Deeter, President and CEO, Ventria Bioscience.


“I am excited to join Ventria’s team and contribute to the mission of delivering affordable healthcare products to children who need it most,” said Semadeni. He continued, “It is a unique opportunity to make a difference for children on a global basis by applying my experience to achieve Ventria’s vision.”


A recent child health study showed that Ventria’s Lactiva and Lysomin helped reduce the duration of diarrhea in children by 30 percent, from 5.2 days to 3.7 days, as part of an oral electrolyte solution. Childhood diarrhea is the second leading killer of children, claiming 2 million lives annually according to the World Health Organization.



For more information, see our website at Ventria Bioscience
http://www.ventria.com

Or contact:
Brandy Sargent, Corporate Communications
BSargent@Ventria.com
(916) 921-6148 ext. 27


Statements in this announcement other than historical data and information constitute forward looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. Potential risks and uncertainties may include, but are not limited to, recent changes in senior management, fluctuations in operating results, market conditions and changes in technology and increased competition.